These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 16463221)

  • 21. Meta-analysis of the literature on diagnostic accuracy of SPECT in parkinsonian syndromes.
    Vlaar AM; van Kroonenburgh MJ; Kessels AG; Weber WE
    BMC Neurol; 2007 Sep; 7():27. PubMed ID: 17764571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Radionuclide techniques in the diagnosis of parkinsonian syndromes].
    Pöpperl G; Tatsch K
    MMW Fortschr Med; 2004 Mar; 146(10):24-6. PubMed ID: 15347073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopamine transporter imaging as a diagnostic tool for parkinsonism and related disorders in clinical practice.
    Ba F; Martin WR
    Parkinsonism Relat Disord; 2015 Feb; 21(2):87-94. PubMed ID: 25487733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and [99mTc]TRODAT-1/[123I]IBZM SPECT imaging findings in dopa-responsive dystonia.
    Hwang WJ; Yao WJ; Wey SP; Ting G
    Eur Neurol; 2004; 51(1):26-9. PubMed ID: 14631126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Differential diagnosis of atypical Parkinsonian syndromes].
    Csóti I; Fornádi F
    Ideggyogy Sz; 2010 Mar; 63(3-4):77-86. PubMed ID: 20405664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imaging studies in movement disorders.
    Seibyl JP
    Semin Nucl Med; 2003 Apr; 33(2):105-13. PubMed ID: 12756643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The expanding role of imaging in prion disease.
    Taber KH; Cortelli P; Staffen W; Hurley RA
    J Neuropsychiatry Clin Neurosci; 2002; 14(4):371-6. PubMed ID: 12426406
    [No Abstract]   [Full Text] [Related]  

  • 28. [Usefulness of SPECT and MRI in the diagnosis of atypical parkinsonism].
    Skogseid IM; Gerdts R; Nyberg-Hansen R; Rootwelt K; Bakke SJ
    Tidsskr Nor Laegeforen; 2001 Nov; 121(29):3399-403. PubMed ID: 11826785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of neuroimaging in the diagnosis of the atypical parkinsonian syndromes in clinical practice.
    Dąbrowska M; Schinwelski M; Sitek EJ; Muraszko-Klaudel A; Brockhuis B; Jamrozik Z; Sławek J
    Neurol Neurochir Pol; 2015; 49(6):421-31. PubMed ID: 26652877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional neuroimaging studies in posttraumatic stress disorder: review of current methods and findings.
    Francati V; Vermetten E; Bremner JD
    Depress Anxiety; 2007; 24(3):202-18. PubMed ID: 16960853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of dopamine transporter SPECT for the practitioner and the general neurologist.
    Oertel WH; Gerstner A; Höffken H; Dodel RC; Eggert KM; Möller JC
    Mov Disord; 2003 Oct; 18 Suppl 7():S9-15. PubMed ID: 14531040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EANM procedure guidelines for brain neurotransmission SPECT/PET using dopamine D2 receptor ligands, version 2.
    Van Laere K; Varrone A; Booij J; Vander Borght T; Nobili F; Kapucu OL; Walker Z; Någren K; Tatsch K; Darcourt J
    Eur J Nucl Med Mol Imaging; 2010 Feb; 37(2):434-42. PubMed ID: 19838704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PET and SPECT functional imaging in Parkinson's disease.
    Antonini A; DeNotaris R
    Sleep Med; 2004 Mar; 5(2):201-6. PubMed ID: 15033144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0.
    Morbelli S; Esposito G; Arbizu J; Barthel H; Boellaard R; Bohnen NI; Brooks DJ; Darcourt J; Dickson JC; Douglas D; Drzezga A; Dubroff J; Ekmekcioglu O; Garibotto V; Herscovitch P; Kuo P; Lammertsma A; Pappata S; Peñuelas I; Seibyl J; Semah F; Tossici-Bolt L; Van de Giessen E; Van Laere K; Varrone A; Wanner M; Zubal G; Law I
    Eur J Nucl Med Mol Imaging; 2020 Jul; 47(8):1885-1912. PubMed ID: 32388612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Should non-movement specialists refer patients for SPECT-DaTSCAN?
    Gajos A; Dąbrowski J; Bieńkiewicz M; Płachcińska A; Kuśmierek J; Bogucki A
    Neurol Neurochir Pol; 2019; 53(2):138-143. PubMed ID: 30855703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Imaging of genetic aspects of Parkinson's disease].
    Brüggemann N; Vegt J; Klein C; Siebner HR
    Nervenarzt; 2010 Oct; 81(10):1196-203. PubMed ID: 20842341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined 123I-FP-CIT and 123I-IBZM SPECT for the diagnosis of parkinsonian syndromes: study on 72 patients.
    Plotkin M; Amthauer H; Klaffke S; Kühn A; Lüdemann L; Arnold G; Wernecke KD; Kupsch A; Felix R; Venz S
    J Neural Transm (Vienna); 2005 May; 112(5):677-92. PubMed ID: 15375677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imaging gait disorders in parkinsonism: a review.
    Maillet A; Pollak P; Debû B
    J Neurol Neurosurg Psychiatry; 2012 Oct; 83(10):986-93. PubMed ID: 22773859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extrapyramidal syndromes: PET and SPECT.
    Tatsch K
    Neuroimaging Clin N Am; 2010 Feb; 20(1):57-68. PubMed ID: 19959018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroimaging of NREM sleep in primary insomnia: a Tc-99-HMPAO single photon emission computed tomography study.
    Smith MT; Perlis ML; Chengazi VU; Pennington J; Soeffing J; Ryan JM; Giles DE
    Sleep; 2002 May; 25(3):325-35. PubMed ID: 12003163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.